Resources Contact Us Home
Immunological composition of measles virus utilizing recombinant poxvirus

Image Number 18 for United States Patent #5759841.

What is described is a recombinant poxvirus, such as vaccinia virus or canarypox virus, containing foreign DNA from Morbillivirus. In one embodiment, the foreign DNA is expressed in a host by the production of a measles virus glycoprotein. In another embodiment, the foreign DNA is expressed in a host by the production of at least two measles virus glycoproteins. What is also described is a vaccine containing the recombinant poxvirus for inducing an immunological response in a host animal inoculated with the vaccine. By the present invention, cross-protection of dogs against canine distemper is obtained by inoculating the dog with the recombinant poxvirus.

  Recently Added Patents
Hydrothermal synthesis of nanocubes of sillenite type compounds for photovoltaic applications and solar energy conversion of carbon dioxide to fuels
Preparation and its use of derivatization reagent for detecting L-carnitine or D-carnitine
Servo write assembly
Method for preparing a .beta.-SiAlON phosphor
Lubricating oil compositions
Method for playing digital media files with a digital media player using a plurality of playlists
System and method for providing private demand-driven pricing
  Randomly Featured Patents
Femtosecond laser pulse measuring system
Magnetic head
Child resistant blister package
Bullet proof garment
Shoulder harness reel assembly with automatic reel lock
Color printer for multi-color printing by superimposing a plurality of toners
Small-sized drill grinding machine
Hydrotalcites, syntheses, and uses
Photo-acoustic detection device and method
DVD recorder